CSIMarket Company Name, Ticker, Industry, else..
 
Bicycle Therapeutics Plc  (NASDAQ: BCYC)
 

Bicycle Therapeutics Plc's Suppliers Performance

BCYC's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
BCYC Costs vs Sales of Suppliers Growth

• More on BCYC Suppliers






Bicycle Therapeutics Plc's Comment on Supply Chain


The company has established agreements with several suppliers and collaborators to support a sustainable radioisotope supply chain. Eckert & Ziegler supplies various radioisotopes and develops and manufactures BRC and BIA molecules. A 15-year contract with the UK Nuclear Decommissioning Authority (UKNDA) provides access to up to 400 tonnes of reprocessed uranium, which serves as a source for lead-212 (212Pb). The company collaborates with the United Kingdom National Nuclear Laboratory (UKNNL) to extract thorium-228 (228Th) from the reprocessed uranium obtained from UKNDA. SpectronRx is developing bespoke 212Pb generators exclusively for the company, with initial quantities of 212Pb already produced. These arrangements support the discovery, development, and commercial supply of BRC molecules containing 212Pb.

Bicycle Therapeutics Plc's Comment on Supply Chain


The company has established agreements with several suppliers and collaborators to support a sustainable radioisotope supply chain. Eckert & Ziegler supplies various radioisotopes and develops and manufactures BRC and BIA molecules. A 15-year contract with the UK Nuclear Decommissioning Authority (UKNDA) provides access to up to 400 tonnes of reprocessed uranium, which serves as a source for lead-212 (212Pb). The company collaborates with the United Kingdom National Nuclear Laboratory (UKNNL) to extract thorium-228 (228Th) from the reprocessed uranium obtained from UKNDA. SpectronRx is developing bespoke 212Pb generators exclusively for the company, with initial quantities of 212Pb already produced. These arrangements support the discovery, development, and commercial supply of BRC molecules containing 212Pb.







BCYC's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Bicycle Therapeutics Plc 287.79 63.50 -219.03 288
SUBTOTAL 0.00 0.00 0.00 -


Sources: Bicycle Therapeutics Plc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Bicycle Therapeutics Plc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.